Open-Label Phase III Long-Term Safety Trial of Liprotamase

Clinical trial NCT00449904 · COMPLETED

Trial details

NCT number: NCT00449904
Sponsor: Anthera Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis Exocrine Pancreatic Insufficiency

Start date: 2007-06-01
Primary completion: 2009-04-01
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.